Monday , December 11 2017
Home / Resources / Videos / Patrick Mooney, MD, CEO, Echo Therapeutics, Q1 Symphony tCGM System

Patrick Mooney, MD, CEO, Echo Therapeutics, Q1 Symphony tCGM System

Dr. Mooney gives a detailed overview of how the revolutionary Symphony CGM system works, without needles or intrusive sensors, with a live demostration of someone using the device.

More videos with Dr. Mooney:

Patrick Mooney, MD, CEO, Echo Therapeutics, Introduction

How Many Patients Could Use the Symphony?

Accuracy of the Symphony and Who Is Using It Now

Patrick Mooney, MD, is the chairman and CEO of Echo Therapeutics and a surgeon by training. He did his surgical residency at Thomas Jefferson University Hospital in Philadelphia after which he left medicine and began working on Wall Street as a securities analyst covering biotechnology companies. He later left Wall Street to run another biotechnology company, and then joined Echo Therapeutics in 2007.

Echo uses a technology that came out of Dr. Robert Langer’s lab at MIT. Dr. Langer invented a device which permeates the skin without needing a needle to penetrate the protective barrier formed by the skin. The device creates a portal into the body to deliver drugs topically or extract analytes, and Echo used this system to create a glucose biosensor, the Symphony tCGM System, to read continuously without the use of a needle.